BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 14710019)

  • 1. [Neurological manifestations of leprosy].
    Grimaud J; Vallat JM
    Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprous neuropathy.
    de Freitas MR; Said G
    Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriately Selected Nerve in Suspected Leprous Neuropathy Yields High Positive Results for
    Vengalil S; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Polavarapu K; Mahajan NP; Raju S; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh B; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Jul; 103(1):209-213. PubMed ID: 32285768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological manifestations of Hansen's disease and their management.
    Agrawal A; Pandit L; Dalal M; Shetty JP
    Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
    Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
    Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leprosy, a neurologic disease].
    Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y
    Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of leprous neuropathy in practice].
    Flageul B
    Rev Neurol (Paris); 2012 Dec; 168(12):960-6. PubMed ID: 23131313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral nerve damage in patients with leprosy].
    Grimaud J
    Rev Neurol (Paris); 2012 Dec; 168(12):967-74. PubMed ID: 23107882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
    Lefford MJ; Hunegnaw M; Siwik E
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leprosy/Hansen's disease in the early 21st century.
    Worobec SM
    Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical, immunological, and histological study of neuritic leprosy patients.
    Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
    Singal A; Sonthalia S; Pandhi D
    Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprous neuropathies.
    Waters MF; Jacobs JM
    Baillieres Clin Neurol; 1996 Mar; 5(1):171-97. PubMed ID: 8732207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
    Stingl P
    Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprous neuromyositis: A rare clinical entity and review of the literature.
    Mitra S; Gunasekaran K; Chacko G; Hansdak SG
    Indian J Med Microbiol; 2016; 34(1):95-7. PubMed ID: 26776128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.